Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Myriad Genetics sell Bank of America Co.

Start price
€13.80
13.12.24 / 50%
Target price
€12.39
13.12.25
Performance (%)
-55.80%
End price
€6.10
14.12.25
Summary
This prediction ended on 14.12.25 with a price of €6.10. The SELL prediction by Bank_of_America_Co_ for Myriad Genetics performed very well with a performance of -55.80%. Bank_of_America_Co_ has a follow-up prediction for Myriad Genetics where he still thinks Myriad Genetics is a Sell. Bank_of_America_Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Myriad Genetics 0.820% 0.820% -54.779%
iShares Core DAX® 0.734% 1.458% 17.980%
iShares Nasdaq 100 -2.686% -0.146% 3.810%
iShares Nikkei 225® -2.261% -2.729% 11.679%
iShares S&P 500 -1.346% 0.467% 1.970%

Comments by Bank_of_America_Co_ for this prediction

In the thread Myriad Genetics diskutieren
Prediction Sell
Perf. (%) -55.80%
Target price 12.385
Change
Ends at 13.12.25

Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target lowered by analysts at Bank of America Co. from $15.00 to $13.00. They now have an "underperform" rating on the stock.
Ratings data for MYGN provided by MarketBeat

In the thread Trading Myriad Genetics
Prediction Sell
Perf. (%) -55.80%
Target price 12.385
Change
Ends at 13.12.25

Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten

Current prediction by Bank_of_America_Co_ for Myriad Genetics

Myriad Genetics

Start price
Target price
Perf. (%)
€10.30
03.03.25
€10.50
03.03.26
-39.32%
07:35